This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Respiratory Medicine:2022: June 7 Full text
Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial.
JAMA:2022: May 15 Full text
Infection Prevention
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
PNAS:2022: June 9 Full text
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19.
New England Journal of Medicine:2022: June 9 Full text
Clinical Practice
In-house testing for COVID-19: effects on length of stay, isolation and the need for inpatient rehabilitation. AUS
Australian Health Review:2022: May 5 Full text
A multi-centre COVID-19 study examining symptoms and medication use in the final week of life. SVHA
Journal of Pain and Symptom Management:2022: May 26 Full text
Pathophysiology and Long Covid
Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET.
MedRxiv:2022: June 4 Full text
Infection Control
Mask wearing in community settings reduces SARS-CoV-2 transmission.
PNAS: 2022: May 31 Full text
Risk of air and surface contamination of SARS-CoV-2 in isolation wards and its relationship with patient and environmental characteristics.
Ecotoxicology and Environmental Safety:2022: June 6 Full text
Vaccines
How are vaccines being adapted to meet the changing face of SARS-CoV-2?
BMJ:2022: June 1 Full text
Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants.
JAMA Internal Medicine:2022: June 1 Full text
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
Lancet Oncology:2022:June 2 Full text
Immunology
SARS-CoV-2 evolution and immune escape in immunocompromised patients.
New England Journal of Medicine:2022: June 8 Full text
